Corinna Weber-Schoendorfer

Summary

Country: Germany

Publications

  1. doi request reprint The safety of cetirizine during pregnancy. A prospective observational cohort study
    Corinna Weber-Schoendorfer
    Pharmakovigilanz und Beratungszentrum Embryonaltoxikologie Berlin, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Reprod Toxicol 26:19-23. 2008
  2. doi request reprint The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study
    Corinna Weber-Schoendorfer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Reprod Toxicol 26:24-30. 2008
  3. ncbi request reprint Fetal outcome after technetium scintigraphy in early pregnancy
    Christof Schaefer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, Berlin 14050, Germany
    Reprod Toxicol 28:161-6. 2009
  4. doi request reprint Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy
    Christof Schaefer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050, Berlin, Germany
    Arch Gynecol Obstet 281:221-7. 2010
  5. ncbi request reprint No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study
    Corinna Weber-Schoendorfer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, Charite Universitatsmedizin Berlin, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Rheumatology (Oxford) 53:757-63. 2014
  6. doi request reprint Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations
    Christof Schaefer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Reprod Toxicol 26:36-41. 2008
  7. pmc Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature
    Marc Oppermann
    Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charite Universitatsmedizin Berlin, 14050 Berlin, Germany
    Br J Clin Pharmacol 75:822-30. 2013

Detail Information

Publications7

  1. doi request reprint The safety of cetirizine during pregnancy. A prospective observational cohort study
    Corinna Weber-Schoendorfer
    Pharmakovigilanz und Beratungszentrum Embryonaltoxikologie Berlin, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Reprod Toxicol 26:19-23. 2008
    ..To assess the safety of cetirizine during pregnancy...
  2. doi request reprint The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study
    Corinna Weber-Schoendorfer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Reprod Toxicol 26:24-30. 2008
    ..To assess the safety of calcium channel blockers during the first trimester of pregnancy...
  3. ncbi request reprint Fetal outcome after technetium scintigraphy in early pregnancy
    Christof Schaefer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, Berlin 14050, Germany
    Reprod Toxicol 28:161-6. 2009
    ..Therefore, clinical data was needed to assess the risk and safety of technetium scintigraphy with respect to prenatal development...
  4. doi request reprint Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy
    Christof Schaefer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050, Berlin, Germany
    Arch Gynecol Obstet 281:221-7. 2010
    ..A detailed investigation of the incidence and outcome of these pregnancies would fill an important gap...
  5. ncbi request reprint No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study
    Corinna Weber-Schoendorfer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, Charite Universitatsmedizin Berlin, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Rheumatology (Oxford) 53:757-63. 2014
    ..The aim of this study was to investigate whether paternal low-dose MTX therapy around conception has an unfavourable effect on pregnancy outcome...
  6. doi request reprint Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations
    Christof Schaefer
    Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
    Reprod Toxicol 26:36-41. 2008
    ....
  7. pmc Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature
    Marc Oppermann
    Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charite Universitatsmedizin Berlin, 14050 Berlin, Germany
    Br J Clin Pharmacol 75:822-30. 2013
    ..This study aimed to assess the risk of fetopathy, the sensitive time window, and possible new symptoms in prospective as well as retrospective cases with AT₁-antagonist treatment during the second or third trimester of pregnancy...